IPOs, Biotech, deals

Archemix Pulls IPO

Rebecca Zacks 2/7/08

There goes another one: Cambridge, MA’s Archemix has withdrawn its planned IPO, citing unfavorable market conditions. The deal was to have been worth up to $63 million. VentureBeat Life Sciences has a good look at the quickly worsening environment for biotech offerings, in case you’re not bummed out enough already.